Elevated expression of S100P, CAPL and MAGE 3 in doxorubicin-resistant cell lines: Comparison of mRNA differential display reverse transcription- polymerase chain reaction and subtractive suppressive hybridization for the analysis of differential gene expression

Anti-Cancer Drugs

Volumn 9, Issue 4, 1998, Pages 311-317

  Bertram, Joachim ^a   Palfner, Karsten ^a   Hiddemann, Wolfgang ^a   Kneba, Michael ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

CAPL; Doxorubicin; MAGE 3; RT PCR; S100P; SSH

Indexed keywords

MESSENGER RNA; PROTEIN S 100;

ARTICLE; CALCIUM METABOLISM; CANCER CELL CULTURE; COLON CARCINOMA; GENE EXPRESSION; HUMAN; HUMAN CELL; MOLECULAR CLONING; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031800720     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199804000-00004     Document Type: Article

References (34)

1. Liang P, Averboukh L, Pardee AB. Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Res 1993; 21: 3269-75.
2. Shen R, Su ZZ, Olsson CA, et al. Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display. Proc Natl Acad Sci USA 1995; 92: 6778-82.
3. Stone B, Wharton, W. Targeted RNA fingerprinting: the cloning of differentially-expressed cDNA fragments enriched for members of the zinc finger gene family. Nucleic Acids Res 1994; 22: 2612-8.
4. van Groningen JJ, Bloemers HP, Swart GW. Identification of melanoma inhibitory activity and other differentially expressed messenger RNAs in human melanoma cell lines with different metastatic capacity by messenger RNA differential display. Cancer Res 1995; 55: 6237-43.
5. Watson JB, Margulies JE. Differential cDNA screening strategies to identify novel stage-specific proteins in the developing mammalian brain. Dev Neurosci 1993; 15: 77-86.
6. Yang X, Nakao Y, Pater MM, et al. Identification of two novel cellular genes associated with multistage carcinogenesis of human endocervical cells by mRNA differential display. Carcinogenesis 1996; 17: 563-7.
7. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of polymerase chain reaction. Science 1992; 257: 967-71.
8. Bauer D, Müller H, Reich J, et al. Identification of differentially expressed mRNA species by an improved display technique (DDRT-PCR). Nucleic Acids Res 1993; 21: 4272-80.
9. Haag E, Raman V. Effects of primer choice and source of Taq DNA polymerase on the banding patterns of differential display RT-PCR. Biotechniques 1994; 17: 226-8.
10. Diatchenko L, Lau YFC, Campbell AP, et al. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 1996; 93: 6025-30.
11. Mou L, Miller H, Li J, et al. Improvements to differential display method for gene analysis. Biochem Biophys Res Commun 1994; 199: 564-9.
12. Chirgwin JM, Przybila AE, MacDonald RJ, et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294-9.
13. Hickey E, Brandon S, Sadis S, et al. Molecular cloning of sequences encoding the human heat-shock proteins and their expression during hyperthermia. Gene 1986; 43: 147-54.
14. Lam M, Vimmerstedt LJ, Schlatter LK, et al. Preferential synthesis of the 78-kD glucose regulated protein in glucocorticoid-treated S49 mouse lymphoma cells. Blood 1992; 79: 3285-92.
15. Misra S, Zafarullah M, Price-Haughey J, et al. Analysis of stress-induced genes in fish cell lines exposed to heavy metals and heat shock. Biochim Biophys Acta 1989; 1007: 325-33.
16. Palfner K, Kneba M, Hiddemann W, Bertram J. Quantification of ribozyme-mediated RNA cleavage using silverstained polyacrylamide gels. BioTechniques 1995; 19: 926-9.
17. Sambrook J, Maniatis T, Fritsch EF. Molecular cloning. A laboratory manual. Cold Spring Harbour, NY: Cold Spring Harbour Laboratory Press 1989.
18. Bagni C, Mariottini P, Annesi F, et al. (1993) GenBank accession L20868 X 73974.
19. Zhang W, Ling V. Insulin-like growth factors affect drug accumulation and P-glycoprotein subcellular localisation in multidrug-resistant ovarian CHRC5 cells. Proc Am Ass Cancer Res 1997; 38: 2591.
20. 2+ binding properties. Eur J Biochem 1992; 207: 541-7.
21. Davies BR, Davies MP, Gibbs FE, et al. Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1. Oncogene 1993; 8: 999-1008.
22. (2+)-binding proteins of the S100 family in malignant human breast-cancer cell lines and biopsy samples. Int J Cancer 1994; 57: 684-90.
23. 2+ and GRP78/BiP. J Cell Physiol 1997; 170: 115-29.
24. Fanciulli M, Bruno T, Cerboni C, et al. Cloning of a novel human RNA polymerase II subunit downregulated by doxorubicin: new potential mechanisms of drug related toxicity. FEBS Lett 1996; 384: 48-52.
25. Iordanov MS, Pribnow D, Magun JL, et al. Ribotoxic stress response: Activation of stress-activated protein kinase JNK1 and immediate-early gene expression by anisomycin and by sequence-specific RNA damage to the alpha-sarcin/ricin loop in the 28S ribosomal RNA. Proc Am Ass Cancer Res 1997; 38: 2970.
26. Joshi CP, Nguyen HT. 5′ untranslated leader sequences of eukaryotic mRNAs encoding heat shock induced proteins. Nucleic Acids Res 1995; 23: 541-9.
27. Takahashi M, Fujii J, Miyoshi E, et al. Elevation of aldose reductase gene expression in rat primary hepatoma and hepatoma cell lines. Int J Cancer 1995; 62: 749-54.
28. Hubbard MJ, Mchugh NJ. Mitochondrial ATP synthase F1-beta-subunit is a calcium-binding protein. FEBS Lett 1996; 391: 323-9.
29. Nelson BD, Luciakova K, Li R, et al. The role of thyroid hormone and promotor diversity in the regulation of nuclear encoded mitochondrial proteins. Biochim Biophys Acta 1995; 1271: 85-91.
30. Mori M, Inoue H, Mimori K, et al. Expression of MAGE genes in human colorectal carcinoma. Ann Surg 1996; 224: 183-8.
31. Russo V, Traversari C, Verrecchia A, et al. Expression of MAGE gene family in primary and metastatic human breast cancer: implications for tumor antigen-specific immunotherapy. Int J Cancer 1995; 64: 216-21.
32. Shichijo S, Tsunosue R, Masuoka K, et al. Expression of the MAGE gene family in human lymphocytic leukemia. Cancer Immunol Immunother 1995; 41: 90-103.
33. Becker JC, Gillitzer R, Brocker EB. A member of the melanoma antigen-encoding gene (MAGE) family is expressed in human skin during wound healing. Int J Cancer 1992; 58: 346-8.
34. DePlaen E, Arden K, Traversari C, et al. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 1994; 40: 360-9.